KR860002268A - 피장(避腸)영양액의 제조방법 - Google Patents

피장(避腸)영양액의 제조방법 Download PDF

Info

Publication number
KR860002268A
KR860002268A KR1019850007005A KR850007005A KR860002268A KR 860002268 A KR860002268 A KR 860002268A KR 1019850007005 A KR1019850007005 A KR 1019850007005A KR 850007005 A KR850007005 A KR 850007005A KR 860002268 A KR860002268 A KR 860002268A
Authority
KR
South Korea
Prior art keywords
concentration
cysteine
replaced
solution
cystine
Prior art date
Application number
KR1019850007005A
Other languages
English (en)
Other versions
KR890002948B1 (ko
Inventor
마사요시(외 3) 사메지마
Original Assignee
마쓰바라 이찌로
다나배세이야꾸 가부시끼가이샤(외 1)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마쓰바라 이찌로, 다나배세이야꾸 가부시끼가이샤(외 1) filed Critical 마쓰바라 이찌로
Publication of KR860002268A publication Critical patent/KR860002268A/ko
Application granted granted Critical
Publication of KR890002948B1 publication Critical patent/KR890002948B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)

Abstract

내용 없음

Description

피장(腸避)영양액의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (18)

  1. 하기 표 1에 나타낸 조성물과 함량의 환원당, 생리 아미노산 및 전해질을 증류수에 용해시켜 혼합함으로써 용약을 제조하고, 생성된 혼합물을 여과하고, 혼합물을 멸균함을 특징으로 하는 피장 영양액의 제조방법.
  3. 단, 시스테인 및/또는 시스틴의 전부 또는 일부를 메티오닌으로 대치할 수 있고, 티로신의 전부 또는 일부를 페닐알라닌으로 대치할 수 있다.
  4. 제1항에 있어서, 용액의 하기의 조성물을 갖는 방법.
  6. 단, 시스테인 및/또는 시스틴의 전부 또는 일부를 매티오닌으로 대치할 수 있고, 티로신의 전부 또는 일부를 페닐알라닌으로 대치할 수 있다.
  7. 제1항에 있어서, 가열에 의해 멸균하는 방법.
  8. 제1항에 있어서, 환원당의 농도가 약 5~9w/v%인 방법.
  9. 제1항에 있어서, 총 아미노산의 농도가 약 2.5~3.5w/v%인 방법.
  10. 제1항에 있어서, 전해질의 농도가 하기와 같은 방법.
  12. 제1항에 있어서, 총 아미노산의 농도(w/v%)와 환원당(글루코오스)의 농도의 곱이 7~25인 방법.
  13. 제1항에 있어서, 유체의 pH가 4.0~6.0인 방법.
  14. 제1항에 있어서, 환원당이 글루코오스 및/또는 말토오스인 방법.
  15. 제8항에 있어서, 용액이 하기의 조성물을 갖는 방법.
  17. 단, 필요하다면 상기 조성물에 약 260~290mg/1의 L-시스테인 및/또는 L-시스테인을 더 가할 수 있다.
  18. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850007005A 1984-09-25 1985-09-24 수액제의 갈변 방지방법 KR890002948B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP201066/84 1984-09-25
JP59201066A JPS6178719A (ja) 1984-09-25 1984-09-25 総合輸液剤
CN85107296.8A CN1003111B (zh) 1984-09-25 1985-10-05 胃肠外营养溶液

Publications (2)

Publication Number Publication Date
KR860002268A true KR860002268A (ko) 1986-04-24
KR890002948B1 KR890002948B1 (ko) 1989-08-14

Family

ID=76224742

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850007005A KR890002948B1 (ko) 1984-09-25 1985-09-24 수액제의 갈변 방지방법

Country Status (8)

Country Link
US (1) US4670261A (ko)
EP (1) EP0176094B1 (ko)
JP (1) JPS6178719A (ko)
KR (1) KR890002948B1 (ko)
CN (1) CN1003111B (ko)
DE (1) DE3563508D1 (ko)
HK (1) HK71089A (ko)
SG (1) SG5889G (ko)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719119A (en) * 1985-12-18 1998-02-17 British Technology Group, Ltd. Parenteral nutrition therapy with amino acids
US4871550A (en) * 1986-09-05 1989-10-03 Millman Phillip L Nutrient composition for athletes and method of making and using the same
SE8704217D0 (sv) * 1987-10-29 1987-10-29 Vinnars Erik Ab Aminosyrakomposition for parenteral neringstillforsel
US5116819A (en) * 1989-05-05 1992-05-26 Clintec Nutrition Co. Enteral diet for patients with pulmonary disease
US5292535A (en) * 1990-06-15 1994-03-08 Regents Of The University Of California Hyperosmotic solutions for isonatremic resuscitation
CH682878A5 (fr) * 1991-11-01 1993-12-15 Nestle Sa Procédé permettant d'éviter le brunissement d'un produit alimentaire.
US5470839A (en) * 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
US5480865A (en) * 1994-02-25 1996-01-02 Parkinson's Charitable Trust Nutritional composition
IT1289754B1 (it) * 1996-12-16 1998-10-16 Professional Dietetics Srl Composizioni a base di aminoacidi
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
US20050054555A1 (en) * 2001-10-19 2005-03-10 Jose Jimeno Kahalalide compounds for use in cancer therapy
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) * 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) * 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
GB0325292D0 (en) * 2003-10-29 2003-12-03 Wivenhoe Technology Ltd Treatment of sugar solutions
US7161029B2 (en) * 2003-12-17 2007-01-09 Ajinomoto Co., Inc. DiL-lysine monosulfate trihydrate crystal and method of making
EP1799052B2 (en) * 2004-09-09 2020-01-08 Société des Produits Nestlé S.A. Methods for the manufacture of nutritional products having improved quality
AU2009268742C1 (en) 2008-07-07 2013-11-28 Pentec Health, Inc. Nutritive compositions and methods of using same
EP3461473B1 (en) * 2009-12-18 2021-09-22 Kaneka Corporation Liquid food composition being semisolidified in the acidic region
CN102883729A (zh) * 2010-01-04 2013-01-16 潘泰克健康公司 营养组合物及其使用方法
BR112012030809A8 (pt) * 2010-06-03 2018-01-02 Stokely Van Camp Inc Misturas de eletrólitos proporcionando reduzido sabor salgado
KR101994456B1 (ko) * 2017-03-15 2019-06-28 이건무 당 수액제 조성물
KR102127826B1 (ko) * 2018-09-14 2020-06-29 이건무 암 치료용 수액제 조성물
CN110923199B (zh) * 2020-01-02 2021-08-27 佛山辅康生物科技有限公司 一种卵细胞激活培养液及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639247A5 (de) * 1979-01-23 1983-11-15 Thera Ges Fuer Patente Aminosaeuren und mineralsalze enthaltende infusionsloesung.
JPS5681515A (en) * 1979-12-07 1981-07-03 Tanabe Seiyaku Co Ltd Amino acid transfusion
JPS56110617A (en) * 1980-02-08 1981-09-01 Ajinomoto Co Inc Nutrient composition for young child
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4438144A (en) * 1980-07-31 1984-03-20 Blackburn George L Amino acid preparation and therapy for treatment of stress and injury
JPS58162515A (ja) * 1982-03-19 1983-09-27 Tanabe Seiyaku Co Ltd 末梢静脈注入用加電解質アミノ酸輸液
JPS58167516A (ja) * 1982-03-29 1983-10-03 Daigo Eiyou Kagaku Kk 糖、アミノ酸、電解質輸液の製造法
IT1212792B (it) * 1983-11-30 1989-11-30 Egidio Aldo Moja Supplemento dietetico e alimento preconfezionato che lo contiene procedimento di preparazione e metodo di somministrazione

Also Published As

Publication number Publication date
CN1003111B (zh) 1989-01-25
US4670261A (en) 1987-06-02
KR890002948B1 (ko) 1989-08-14
JPH0414647B2 (ko) 1992-03-13
SG5889G (en) 1989-10-13
JPS6178719A (ja) 1986-04-22
EP0176094A1 (en) 1986-04-02
HK71089A (en) 1989-09-08
CN85107296A (zh) 1987-04-08
EP0176094B1 (en) 1988-06-29
DE3563508D1 (de) 1988-08-04

Similar Documents

Publication Publication Date Title
KR860002268A (ko) 피장(避腸)영양액의 제조방법
Ramamurthy et al. Diabetes increases collagenase activity in extracts of rat gingiva and skin
ATE294597T1 (de) Lösung für die peritonealdialyse
NO875299L (no) Insulinpreparat for ikke-paranteral administrasjon.
DE3852140D1 (de) Produktion von Proteinen in aktiven Formen.
NO165277C (no) Fremgangsmaate for fremstilling av en stabil, vandig, sur opploesning av cis-platina.
DE58903113D1 (de) Behandlung von durch glucose ausgeloester quervernetzung von collagen bei diabetes mellitus-patienten durch arginin, spermidin, kreatin oder agmatin.
US2738299A (en) Stable nutritive amino acid compositions
Larner et al. ACTION OF INTESTINAL EXTRACTS ON “BRANCHED” OLIGOSACCHARIDES1
TW370616B (en) A method for quantitative determination of bilirubin and the reagent composition thereof
EP1429716B1 (en) Cosmetic preparation with anti-wrinkle action
Nagendra et al. Role of glutathione reductase system in disulfiram conversion to diethyldithiocarbamate
SE8600987D0 (sv) Forfarande for framstellning av ett protein- koncentrat ur helblod
KR870004142A (ko) 인터로이킨-2 유도체의 제조방법
FI904618A0 (fi) Menetelmä vesiliuoksen proteiinipitoisuuden lisäämiseksi
GB1391746A (en) Stimulative composition and process for its production
KR860003011A (ko) (-)시스-1,2-에폭시프로필포스폰산과 아미노산과의 염을 함유하는 수용성 제약 조성물
KR920011492A (ko) 시플로플록사신의 주사용 조성물 및 그 제조방법
Nanninga Effect of Heat on the Kinetic Constants of Myosin–Adenosine Triphosphatase
IT1184287B (it) Composizione per la preparazione di un medicamento da usare per la cura della piorrea alveolare
GB1492441A (en) Confirming a desired heat effect on a material
Maeda Comparative studies of bovine serum transferrins
Collentine On the efficacy and safety of glycine administered by vein
Ivanov EXPERIMENTAL STUDIES OF THE INFLUENCE OF HIGH DOSES OF VITAMINS A AND Е ON THE 5'NUCLEOTIDASE AND ADENYLPYROPHATASE ACTIVITY AND ON THE QUANTITY OF THE THIOL GROUPS IN THE HEART MUSCLE OF WHITE RATS
JPS57206377A (en) Improved preparation of wine

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040701

Year of fee payment: 16

EXPY Expiration of term